搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
GEN
2 天
Weight Loss Drug Curbs Appetite, Burns Energy, Skips Side Effects
Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...
2 天
Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?
Right now, Viking does not have any treatments that are formally approved by the FDA. Nevertheless, the company's lead ...
ThePrint
3 天
Ozempic on steroids? Successor that could cut down weight in half the time coming soon
While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...
来自MSN
4 天
Novo Stock Has Been Slammed. How a New Weight-Loss Drug Could Boost Shares by 10%.
While semaglutide works by hampering appetite and controlling blood sugar levels by mimicking the GLP-1 hormone, cagrilintide ...
24/7 Wall St
4 天
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈